119 - Pan-cancer prevalence and immunogenomic landscape of GNAQ/11 mutations across two large clinical-genomic cohorts
Erick Saldanha, MD
12:15-1:45pm & 5:30-7pm MT
Exhibit Hall

345 - Neoantigen-targeted adoptive cell therapy in bladder cancer: Feasibility of isolating and enriching tumor-reactive infiltrating lymphocytes
Fatema Khambati
12:15-1:45pm & 5:30-7pm MT
Exhibit Hall

351 - Dual stimulation of CD40 and 41BB pathways during ex-vivo TIL expansion enhances CD8 T cell expansion
Renata Rossetti, PhD
12:15-1:45pm & 5:30-7pm MT
Exhibit Hall

699 - A CRISPR-Cas9 screen identifies negative regulators of CXCL9 expression by dendritic cells
Achintyan Gangadharan
12:15-1:45pm & 5:30-7pm MT
Exhibit Hall

803 - Hybrid bleb–adhesion migration sets the speed limit for T cell trafficking
W. Gregory Sawyer, PhD
12:15-1:45pm & 5:30-7pm MT
Exhibit Hall

875 - Paradoxical MAPK Hyperactivation Drives Anti-PD1 Responses through the Inflammatory Secretome
Kenneth Tsai, MD, PhD
2:15-1:45pm & 5:30-7pm MT
Exhibit Hall

277 - First-in-Human Clinical Trial for Breast Cancer Leptomeningeal Disease Induces Adaptive Immunity and Transcriptomic Immune Remodelling in the Cerebral Spinal Fluid
Vincent Law, MSc
2:00-2:14pm MT
West Building 300 Level | 301D 

90 - Ablative radiotherapy partitions bone-metastatic prostate cancer into immune-access niches and macrophage-associated clearance sinks
Tao Li
12:15-1:45pm & 6:40-8:10pm MT
Exhibit Hall

230 - Dynamic changes in the bone marrow niche following CD19-targeted CAR-T cell therapy for large B cell lymphoma (LBCL)
Timothy Shaw, PhD
12:15-1:45pm & 6:40-8:10pm MT
Exhibit Hall

506 - Preclinical Evaluation of Intrathecal TRP1-Targeted CAR-T Cells Demonstrates Durable Antitumor Immunity in Melanoma Leptomeningeal Disease
Peter Forsyth, MD
12:15-1:45pm & 6:40-8:10pm MT
Exhibit Hall

642 - Radiation-induced evolutionary double-bind with natural killer cell immunotherapy: a rationale for combination with radiopharmaceutical therapy in prostate cancer
Kimberly Luddy
12:15-1:45pm & 6:40-8:10pm MT
Exhibit Hall

806 - Chemotherapy Class Determines the Magnitude and Mechanism of IL-1α Release from Breast Cancer Cells
Maryam Ayazi, PhD
12:15-1:45pm & 6:40-8:10pm MT
Exhibit Hall

980 - Polygenic risk score associated with immune checkpoint inhibitor (ICI)-mediated pancreatitis in patients with melanoma
Ahmad Tarhini, MD, PhD
12:15-1:45pm & 6:40-8:10pm MT
Exhibit Hall

1147 - Starvation-Induced Acquisition of Macrophage Organelles by Tumor Cells
Olabisi Osunmakinde
12:15-1:45pm & 6:40-8:10pm MT
Exhibit Hall

1166 - Melanoma–intrinsic STING signaling drives tertiary lymphoid structure formation
Rana Falahat, PhD
12:15-1:45pm & 6:40-8:10pm MT
Exhibit Hall